FDA news: FDA cautions of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
On Monday, the American Food and Drug Administration is requiring new safety warnings on all GLP-1 drugs following finding proof of a potential grew risk of a rare eye condition, the agency stated. NAION cases have been reported for all at present marketed GLP-1 products…
In this article
In today's FDA news news, on Monday, the American Food and Drug Administration is requiring new safety warnings on all GLP-1 drugs following finding proof of a potential grew risk of a rare eye condition, the agency stated. NAION cases have been reported for all at present marketed GLP-1 products, the FDA stated.
Key points
- NAION is a condition that can result in sudden fell vision, including permanent vision loss.
- Several observational studies also identified a went up risk, supporting the FDA's fears.
- CNBC has touched out to Ozempic and Wegovy maker Novo Nordisk and Eli Lilly.
FDA news: the details
NAION is a condition that can result in sudden fell vision, including permanent vision loss. CNBC has touched out to Ozempic and Wegovy maker Novo Nordisk and Eli Lilly, the firm behind Mounjaro, Zepbound and Foundayo, for comment. Several observational studies also identified a went up risk, supporting the FDA's fears.
Why traders are watching FDA news
News that changes the outlook for growth, inflation or interest rates can move currencies, bonds, commodities and stocks. Traders weigh each headline for what it means for central-bank policy and risk appetite.
Unexpected developments often lead to higher volatility, so position sizing and risk management become especially important around breaking news.
Market reaction and data
Crypto prices at the time of writing, from Binance spot data (2026-11-10 07:57 UTC):
| Asset | Last price (USDT) | 24h change | 24h high | 24h low |
|---|---|---|---|---|
| Bitcoin (BTC) | 74,918.40 | 1.45% | 75,568.18 | 73,750.00 |
| Ethereum (ETH) | 2,119.53 | 1.36% | 2,151.90 | 2,089.42 |
On the currency side, the latest ECB daily reference rates (2026-11-09) show EUR/USD 1.1193. These are reference fixes, not live quotes.
What to watch next for FDA news
Traders will look for follow-up statements, official data and the reaction in major currency pairs, gold and stock indices.
Key scheduled releases on the economic calendar:
- USD Core CPI m/m on Tue Nov 10, 13:30 UTC, forecast 0.2%, previous 0.3%
- USD CPI m/m on Tue Nov 10, 13:30 UTC, forecast 0.3%, previous 0.6%
- GBP GDP m/m on Thu Nov 12, 07:00 UTC, forecast 0.0%, previous 0.1%
- USD Core PPI m/m on Fri Nov 13, 13:30 UTC, forecast 0.3%, previous 0.7%
- USD PPI m/m on Fri Nov 13, 13:30 UTC, forecast 0.4%, previous 1.3%
Follow every update in our Top 10 Breaking Market News, read Trump states Iran war to end 'fairly soon,' plays down prospects of new strikes or see all of today's top market news.
FAQ
What is the latest FDA news news?
On Monday, the American Food and Drug Administration is requiring new safety warnings on all GLP-1 drugs following finding proof of a potential grew risk of a rare eye condition, the agency stated.
How should traders react to breaking news?
Wait for confirmation from reliable sources, watch how prices react around key levels and manage risk carefully, as spreads and volatility can rise sharply.
Where does this information come from?
This report is based on coverage from CNBC World, checked against market data where available. It is a summary for information only and not investment advice.
Risk warning: This article is for information only and is not investment advice. Trading forex, CFDs, stocks and crypto carries a high risk of losing money. Prices move fast – check live quotes before you trade.
